Georg M. N. Behrens

20.9k total citations · 3 hit papers
166 papers, 6.8k citations indexed

About

Georg M. N. Behrens is a scholar working on Infectious Diseases, Emergency Medicine and Virology. According to data from OpenAlex, Georg M. N. Behrens has authored 166 papers receiving a total of 6.8k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Infectious Diseases, 38 papers in Emergency Medicine and 37 papers in Virology. Recurrent topics in Georg M. N. Behrens's work include HIV-related health complications and treatments (38 papers), HIV Research and Treatment (37 papers) and SARS-CoV-2 and COVID-19 Research (30 papers). Georg M. N. Behrens is often cited by papers focused on HIV-related health complications and treatments (38 papers), HIV Research and Treatment (37 papers) and SARS-CoV-2 and COVID-19 Research (30 papers). Georg M. N. Behrens collaborates with scholars based in Germany, United States and United Kingdom. Georg M. N. Behrens's co-authors include Reinhold Schmidt, William R. Heath, Federico Carbone, Gabrielle T. Belz, Matthias Stoll, Metodi V. Stankov, Alexandra Dopfer‐Jablonka, Reinhold E. Schmidt, Nicholas S. Wilson and Jóse A. Villadangos and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Georg M. N. Behrens

160 papers receiving 6.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic

2021 557 citations Markus Hoffmann, Nadine Krüger et al. profile →
Cross‐presentation, dendritic cell subsets, and the generation of immunity to cellular antigens

2004 543 citations Georg M. N. Behrens et al. profile →
SARS-CoV-2 BA.2.86 enters lung cells and evades neutralizing antibodies with high efficiency

2024 49 citations Amy Kempf, Inga Nehlmeier et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Georg M. N. Behrens Germany	40	2.7k	2.5k	1.5k	1.2k	1.0k	166	6.8k
Daniel M. Altmann United Kingdom	43	2.2k 0.8×	3.8k 1.5×	694 0.5×	1.9k 1.6×	1.6k 1.5×	162	9.2k
Jonathan B. Angel Canada	41	1.9k 0.7×	1.8k 0.7×	547 0.4×	1.7k 1.4×	1.4k 1.3×	177	5.5k
Taisheng Li China	40	5.0k 1.9×	1.3k 0.5×	696 0.5×	1.6k 1.4×	1.5k 1.5×	245	8.4k
Maria Carla Re Italy	35	1.5k 0.6×	1.1k 0.4×	751 0.5×	1.9k 1.6×	1.2k 1.1×	258	4.6k
Jeffrey Laurence United States	40	2.4k 0.9×	1.6k 0.7×	475 0.3×	995 0.8×	935 0.9×	130	5.4k
Scott F. Sieg United States	36	1.4k 0.5×	2.6k 1.1×	1.1k 0.7×	2.7k 2.2×	1.3k 1.3×	111	5.4k
Nichole R. Klatt United States	35	1.7k 0.6×	2.0k 0.8×	775 0.5×	2.6k 2.2×	1.3k 1.3×	109	5.1k
Andrew D. Badley United States	46	2.7k 1.0×	2.0k 0.8×	534 0.4×	2.7k 2.3×	1.8k 1.8×	195	6.6k
Gitte Kronborg Denmark	42	2.6k 1.0×	1.1k 0.4×	2.2k 1.5×	1.7k 1.4×	2.2k 2.2×	168	6.5k
Jan van Lunzen Germany	42	3.1k 1.1×	2.0k 0.8×	759 0.5×	3.7k 3.1×	1.3k 1.2×	145	6.2k

Countries citing papers authored by Georg M. N. Behrens

Since Specialization

Citations

This map shows the geographic impact of Georg M. N. Behrens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Georg M. N. Behrens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Georg M. N. Behrens more than expected).

Fields of papers citing papers by Georg M. N. Behrens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Georg M. N. Behrens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Georg M. N. Behrens. The network helps show where Georg M. N. Behrens may publish in the future.

Co-authorship network of co-authors of Georg M. N. Behrens

This figure shows the co-authorship network connecting the top 25 collaborators of Georg M. N. Behrens. A scholar is included among the top collaborators of Georg M. N. Behrens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Georg M. N. Behrens. Georg M. N. Behrens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Alagaratnam, Jasmini, Kathrin van Bremen, Georg M. N. Behrens, et al.. (2025). Statin use in HIV: European AIDS Clinical Society guidance for the primary prevention of cardiovascular disease. The Lancet HIV. 12(5). e382–e392. 5 indexed citations

Cossmann, Anne, Metodi V. Stankov, Frank Klawonn, et al.. (2025). Impaired Hepatitis B and COVID-19 vaccination responses show strong concordance in hemodialysis patients with end stage renal disease. European journal of medical research. 30(1). 34–34.

Krings, Amrei, Christian Kollan, Daniel Schmidt, et al.. (2024). Characterising HIV-Indicator conditions among two nationwide long-term cohorts of people living with HIV in Germany (1999–2023). Infection. 53(3). 1013–1028.

Ahrenstorf, Gerrit, et al.. (2023). Status of HIV and comorbidities in refugees with HIV from Ukraine. HIV Medicine. 25(4). 479–483. 1 indexed citations

Kuhlmann, Ellen, Marius‐Ionuț Ungureanu, Georg M. N. Behrens, et al.. (2023). Migrant healthcare workers during COVID-19: bringing an intersectional health system-related approach into pandemic protection. A German case study. Frontiers in Public Health. 11. 1152862–1152862. 1 indexed citations

Hummers, Eva, Frank Müller, Dominik Schröder, et al.. (2023). How do immunocompromised people experience the changes in their working lives during the COVID-19 pandemic? Results from a mixed-methods study in Germany. Heliyon. 9(10). e20344–e20344. 1 indexed citations

Pich, Andreas, et al.. (2022). Proteomic Profiling and T Cell Receptor Usage of Abacavir Susceptible Subjects. Biomedicines. 10(3). 693–693. 1 indexed citations

Dulovic, Alex, Monika Strengert, Gema Morillas Ramos, et al.. (2022). Diminishing Immune Responses against Variants of Concern in Dialysis Patients 4 Months after SARS-CoV-2 mRNA Vaccination. Emerging infectious diseases. 28(4). 743–750. 13 indexed citations

Mikuteit, Marie, Anne Cossmann, Ralf Gutzmer, et al.. (2022). Immunogenicity of COVID-19 Vaccination in Melanoma Patients under Immune Checkpoint Blockade. Oncology. 100(7). 392–398. 6 indexed citations

10.

Hammerschmidt, Swantje I., Berislav Bošnjak, Günter Bernhardt, et al.. (2021). Neutralization of the SARS-CoV-2 Delta variant after heterologous and homologous BNT162b2 or ChAdOx1 nCoV-19 vaccination. Cellular and Molecular Immunology. 18(10). 2455–2456. 29 indexed citations

11.

Strengert, Monika, Matthias Becker, Gema Morillas Ramos, et al.. (2021). Cellular and humoral immunogenicity of a SARS-CoV-2 mRNA vaccine in patients on haemodialysis. EBioMedicine. 70. 103524–103524. 44 indexed citations

12.

Hoffmann, Markus, Heike Hofmann-Winkler, Nadine Krüger, et al.. (2021). SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccination. Cell Reports. 36(3). 109415–109415. 162 indexed citations

13.

Behrens, Georg M. N., Anne Cossmann, Metodi V. Stankov, et al.. (2020). Perceived versus proven SARS-CoV-2-specific immune responses in health-care professionals. Infection. 48(4). 631–634. 45 indexed citations

14.

Happle, Christine, Christian Dopfer, Diana Ernst, et al.. (2019). Pediatric Healthcare Utilization in a Large Cohort of Refugee Children Entering Western Europe During the Migrant Crisis. International Journal of Environmental Research and Public Health. 16(22). 4415–4415. 7 indexed citations

15.

Ryom, Lene, Christoph Boesecke, Margherita Bracchi, et al.. (2018). Highlights of the 2017 European AIDS Clinical Society (EACS) Guidelines for the treatment of adult HIV‐positive persons version 9.0. HIV Medicine. 19(5). 309–315. 100 indexed citations

16.

Wetzke, Martin, Christine Happle, Diana Ernst, et al.. (2018). Healthcare Utilization in a Large Cohort of Asylum Seekers Entering Western Europe in 2015. International Journal of Environmental Research and Public Health. 15(10). 2163–2163. 19 indexed citations

17.

Dopfer‐Jablonka, Alexandra, Georg M. N. Behrens, Christian Dopfer, et al.. (2016). Tetanus and diphtheria immunity in refugees in Europe in 2015. Infection. 45(2). 157–164. 28 indexed citations

18.

Dopfer‐Jablonka, Alexandra, Christine Happle, Ulrike Grote, et al.. (2016). Measles, mumps, rubella, and varicella seroprevalence in refugees in Germany in 2015. Infection. 44(6). 781–787. 50 indexed citations

19.

Krishnaswamy, Jayendra Kumar, Adan Chari Jirmo, Abdul Mannan Baru, et al.. (2012). Toll-Like Receptor–2 Agonist–Allergen Coupling Efficiently Redirects Th2 Cell Responses and Inhibits Allergic Airway Eosinophilia. American Journal of Respiratory Cell and Molecular Biology. 47(6). 852–863. 11 indexed citations

20.

Salguero, Gustavo, Bala Sai Sundarasetty, Sylvia Borchers, et al.. (2011). Preconditioning Therapy with Lentiviral Vector-Programmed Dendritic Cells Accelerates the Homeostatic Expansion of Antigen-Reactive Human T Cells in NOD.Rag1 ^−/− .IL-2rγc ^−/− mice. Human Gene Therapy. 22(10). 1209–1224. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact